DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Sheel Biotech Limited — Board Meeting Intimation

NSE 6d ago·25 Aug 2026, 11:19 am

Sheel Biotech

Sheel Biotech Limited has announced that its board will meet on August 31, 2026, to consider 'other business.' This is a standard corporate procedure that allows the board to discuss and approve various non-routine matters that do not fall under the usual agenda of routine meetings.

For investors, this meeting is a key event to watch as it may lead to significant corporate actions. The company has not yet specified the agenda items, so traders should look for an update following the meeting to understand the potential impact on the stock.

Investors should wait for the official disclosure to see if the 'other business' involves strategic partnerships, new product launches, or other developments that could influence the company's future growth and stock performance.